LYTIR

Insider · SEC Form 4 · Director

James N. Wilson

Filed with the SEC as WILSON JAMES N; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: sold $5.1M of CORT. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $5.1M in total.Jun: Insider sales $832KJul: Insider sales $883KAug: Insider sales $1.1MSep: Insider sales $1.1MOct: Insider sales $1.1MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $5.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. CORTSold: CORCEPT THERAPEUTICS INC Oct 15, 2026 10,000 shares filed Oct 16, 2026 3 transactions 10b5-1 plan filing $1.1M
  2. CORTSold: CORCEPT THERAPEUTICS INC Sep 15, 2026 10,000 shares filed Sep 16, 2026 3 transactions 10b5-1 plan filing $1.1M
  3. CORTSold: CORCEPT THERAPEUTICS INC Aug 14, 2026 10,000 shares filed Aug 18, 2026 3 transactions 10b5-1 plan filing $1.1M
  4. CORTSold: CORCEPT THERAPEUTICS INC Jul 15, 2026 10,000 shares filed Jul 17, 2026 4 transactions 10b5-1 plan filing $883K
  5. CORTSold: CORCEPT THERAPEUTICS INC Jun 16, 2026 10,000 shares filed Jun 18, 2026 2 transactions 10b5-1 plan filing $832K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.